1d
Medical Device Network on MSNFDA clears Caristo’s AI-powered CAD diagnostic softwareThe software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.
Leqembi has been shown to successfully reduce amyloid plaques in the brain. (It’s actually the second drug shown to do this; the first one was Aduhelm.) Amyloid plaque is a substance that may ...
YESINTEK has been approved by the US FDA for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic ...
The PM suggests Australians should buy local goods instead of American ones ahead of a federal budget expected to have an "Australian-made" theme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results